Pharmaceuticals, Biotechnology and Life Sciences
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive…
Statistically and clinically significant effects on pruritus, xanthomas and growth maintained for up to four years of treatment in Alagille…
— Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy — — Improved Markers of…
AXA1665 enhances amino acid metabolism and improves ammonia disposal in subjects with mild and moderate hepatic insufficiency AXA1125 impacts key…
Pivotal trial will study the intravenous administration of the Company’s Trappsol® Cyclo™ drug and will focus on systemic and neurologic…
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…
— AI-Based Tools for Liver Histology Assessment Contribute to Gilead’s Broader Efforts to Improve Understanding of NASH — — Data…
LEXINGTON, Mass.–(BUSINESS WIRE)–#LiverMtg19–Fractyl Laboratories Inc. (Fractyl) today announced positive results from the Revita-2 trial evaluating Revita DMR (duodenal mucosal resurfacing)…
– exoIL-12 demonstrates tumor-retained and dose-dependent pharmacology with superior anti-tumor efficacy compared to soluble recombinant IL-12 – – exoSTING shows…
Data Presented at the 2019 American College of Allergy, Asthma and Immunology Annual Meeting OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited…